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Retinopathy of prematurity (ROP) is a leading cause of blindness in children and one 
of the most important reasons of blindness in the perinatal period. 
The aim of the paper was to present a nine-month-old baby boy with esotropia, 
microphtalmos and completely detached retina in one eye, as the end stage of the 
disease, who had not been checked for ROP. The boy was born in  the 32nd  gestational 
week, with 1670 g birth weight. Indirect ophthalmoscope examination and 
ultrasonography of the left eye showed stage 5 retinopathy of prematurity. On the right 
eye, the finding was valid. 
Retinopathy of prematurity today needs recognition, understanding and awareness 
among ophthalmologists, pediatricians, neonatologists. Early diagnosis of damage is 
important in the treatment of ROP. Acta Medica Medianae 2012; 51(1):37-41. 
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Introduction 
 
Retinopathy of prematurity (ROP) has being 
increasingly recognized as an important cause of 
childhood blindness in industrialized and developing 
countries (1). It is a very serious disorder, 
previously known as retrolental fibroplasias (Terry, 
1942) (2), which is characterized by abnormal 
vascular development of retina in premature infants 
(3). Low gestational age (especially <32 weeks of 
gestation), low birth weight (<1500g, especially 
<1250g), sepsis and oxygen therapy are dominate 
risk factors for this condition (4-11). Neonatal 
sepsis, oxygen exposure and low gestational age 
may have synergistic effects, while oxygen 
exposure and sepsis may have antagonistic 
effects on developing ROP (11). Also, high blood 
concentrations of oxygen and carbon dioxide 
(9,12) and low blood pH are associated with 
increased risk of severe ROP (12). Other risk 
factors for ROP are concurrent illness (9), heart 
disease, infection, apnea, respiratory distress, 
bradycardia, white race, intraventricular hemorrhage, 
prolonged parenteral nutrition, lung maturation, 
steroid treatment, blood transfusions (4,10) and  
maternal factors such as preeclampsia, heavy 
smoker, older maternal age, multiple births, in 
vitro fertilization (10) etc.  
The International Classification of Retinopathy 
of Prematurity (ICROP) uses a number of 
parameters to describe the disease. Disseses are 
classified according to zones they affect (1, 2, 
and 3), the circumferential extent of the disease 
based on the clock hours (1-12), the severity of 
the disease (stage 1-5) and the presence or 
absence of "Plus Disease"(13). Stage 5 is the 
severest form of ROP, the final stage of the 
disease and the main cause of visual impairment 
and blindness. This stage is a total retinal 
detachment in the shape of a funnel - stage 5A is 
an open funnel and stage 5B is a closed funnel. 
However, even milder forms of ROP leave ocular 
sequel in the form of ametropias, refractive 
errors (especially myopia), strabismus, glaucoma, 
cataracts (14).  
Treatment for ROP might include: a) 
cryotherapy (freezing) to prevent the spread of 
abnormal blood vessels; it was the original mode 
of treatment since the 1970s.; b) Laser surgery 
(eg, xenon, argon and diode) has shown to be as 
effective as cryotherapy for ROP; c) Scleral 
buckling surgery and/or vitrectomy was 
performed for stages 4 and 5, but with the poor 
anatomical and visual prognosis (4, 15,16).  
In January 2008, the implementation of the 
screening of premature babies for ROP in the 
region of Niš started. All premature neonates 
included in the examination had birth weight  of 
2000g or less and/or gestational age of 37 weeks 
or less; also, there were other neonates born 
after the 37th gestational week, however, with 
some other associated risk factors (oxygen, 
ventilation, sepsis, etc).  Stage 5 retinopathy of prematurity in one eye – case report                                                            Gordana Stanković-Babić et al. 
The aim of our study was to present a child 
with ROP stage 5 and microphthalmus on the 
same eye, which had not been previously checked 
for ROP.  
 
A case report   
 
A case of a nine-month-old  preterm child, 
of male sex presented with deformed head due to 
the previous operations for hydrocephalus and 
with an asymmetrical face. The left eye globe 
was smaller than the right one, with an 
esodeviation. The parents brought the child to 
the Children’s Pediatric Clinic because of the left 
eye sliding. The child was referred from the 
center where screening for ROP had not been 
performed.  
The baby is the first child from the first 
regular pregnancy. The mother (22 years old) 
was a heavy smoker. A preterm baby, 32 weeks 
of gestation, birth weight 1670g, with a 
respiratory distress syndrome, icterus, APS 6/7, 
oxygen therapy. The subsequent controls found 
hydrocephalus for which the child had been 
operated on two occasions when the pumps were 
installed. Family history was negative. A regular 
finding was obtained after performing a dilated 
retinal examination.   
 
 
 
Figure 1 Microphthalmus and esotropia 
 
Ophthalmic examination of anterior segment 
showed a small left eye globe, with an 
esodeviation, moving in all directions, but did not 
follow the light (Figure 1.). The red reflex was 
present only on the right eye. Leukocoria was 
present on the left eye (Figure 2). Corneal 
diameters were 9.5 mm on the right eye and 8 
mm on the left eye. Electro diagnostic tests were 
undertaken - VEP on the right eye showed 
weaker cortical responses, amplitude and latency 
in physiological limits. Neovascularization of the 
iris on both eyes was absent. The child was 
examined by indirect ophthalmoscope with +20 D 
lens with a full dilatation of the pupils 
(sol.Tropicamid 0.5% and sol. Phenylephrine 1% 
combination drops). Examination of anterior and 
posterior segments of the right eye was normal. 
Computerized refractometry (Righton Speedy-K, 
Japan) showed the presence of oblique 
astigmatism on the right eye +0.75/+1.75 160°). 
The measurement of axial length by ultra-
sonography  A scan were Lax = 17.5 mm right 
eye (Figure 3). B scan - total ablation of the 
retina on the left eye which was smaller (Figure 
4). Electrodiagnostic tests, such as VEP, were 
undertaken. The right eye showed weaker cortical 
responses, amplitude and latency in physiological 
limits. Genetic examination showed normal male 
kariotype. 
 
 
 
Figure 2 Leucokoria of the left eye 
 
 
 
Figure 3 A scan of the right eye 
 
 
 
Figure 4 B scan of the left eye 
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The therapy involved the correction of the 
right eye +0.25 /+ 0.75 160°, and eye prosthesis 
(the cosmetic aspect and the social interaction of 
the patient) in future for the left eye. 
The neurologist was satisfied with the 
findings at the last follow-up examination. The 
parents were introduced to the nature of the 
disease. 
 
Discussion 
 
Retinopathy of prematurity is important 
(1,2), but a potentially preventable cause of 
childhood blindness (17). 
The introduction of intensive care units into 
neonatal nurseries has caused a significant 
increase in the survival rate of infants of very low 
birth weight (500-1500g) with significant increase 
of ROP (18). In general, more than 50% of 
premature infants weighing less than 1250 g at 
birth show evidence of ROP, and about 10% of 
the infants develop stage 3 ROP. The incidence of 
ROP is more frequent in white infants than in 
black infants and in male infants than in female 
infants (19). 
The unique feature of ROP relates to its 
occurrence only in premature infants with 
immature and incompletely vascularised retina 
(16). The development of the human retinal 
vasculature commences at approximately the 
16th week of gestation and concludes at term 
(i.e., the 40th week of gestation) (20). 
Understanding both the mechanisms of normal 
retinal vascular development and the patho-
physiological processes ROP is the key to 
developing new therapeutic approaches to 
prevent complications of the ROP (21).  
A promising future strategy to counter ROP 
is to use anti-VEGF therapy (VEGF-specific 
neutralizing antibody, bevacizumab). Timing (stage/ 
zone of ROP), dose (0.4–12.5 mg intravitreal), and 
frequency of administration of bevacizumab, as well 
as a co-treatment with photocoagulation, varied 
tremendously among reports (22). In the future, 
evaluation of candidate genetic polymorphism 
influencing the outcome of ROP may provide new 
information about the pathogenesis of the 
disease. Screening of genetic polymorphisms 
may also help to identify and treat those infants 
who are at high risk in a timelier manner (19).  
Early diagnosis of damage is important in 
the treatment of ROP. In November 2009, on a 
World ROP Congress in New Delhi, screening 
criteria for premature babies were modified. The 
first ophthalmology exam depending on the 
baby’s gestational age should be 1-3 weeks after 
birth. Babies born at 34 weeks or later have their 
exam at 1 week after birth. Those born earlier 
have exams later at 2 weeks (31, 32 and 33 
gestational age) or 3 weeks after birth, for a 
baby of a very low gestational age. Follow-up 
examinations are determined based on the 
results of the first exam. Babies do not need 
another examination if the blood vessels in both 
retinas have completed normal development.  
Early treatment has shown to improve a 
baby’s chances for normal vision. Laser 
treatment should start within 72 hours of the eye 
exam. Some babies with “plus disease” need 
immediate treatment (15,16).      
Approximately 20% of all premature babies 
can develop some form of strabismus or 
refractive error by the time. This is why babies 
who are younger than 32 weeks or less than 
1500 g receive follow-up care every six months, 
whether or not ROP is present (19). During the 
first months of life, preterm infants demonstrated 
more myopia, astigmatism and anisometropia 
than full-term infants did (13,18,23-28). 
Recommendations for follow-up examinations 
must include all aspects of visual function, i.e., 
visual acuity, contrast sensitivity, visual fields, 
refraction, strabismus, and perceptual problems 
(24).  
Children born prematurely were reported to 
have an increased incidence of visual impairment, 
because of retinopathy of prematurity, but also 
because of perinatal lesions in the brain (29).  
Microphthalmus is a congenital ocular 
anomaly. There is no predilection with respect to 
gender or race; it can be simple or complex (30), 
unilateral or bilateral, in over 50% of cases it is 
associated with systemic abnormality. Epidemio-
logical data indicate the following risk factors: 
maternal age (over  40 years of age), multiple 
pregnancies, children low birth weight, low 
gestational age (31), prenatal infection of rubella, 
cytomegalovirus, fetal alcohol syndrome (32) and 
others. 
We present a child with ROP stage 5 and 
microphthalmus on the same eye, who had not 
been previously checked for ROP. Risk factors for 
ROP are: prematurely born infant, low gestational 
age, a respiratory distress syndrome, icterus, 
oxygen exposure, hydrocephalus for which the 
child was operated on two occasions, young age 
of a mother who was a heavy smoker. Risk 
factors for microphthalmus are low birth weight 
and low gestational age of a child. The differential 
diagnostic problems that must be observed in a 
presented case involve persistent hyperplasic 
primary vitreous (PHPV) or persistent fetal 
vasculature (PFV) as a developmental ocular 
abnormalities consisting of a varied degree of 
glial and vascular proliferation in vitreous cavity. 
It is usually associated with a slightly small eye. 
Retinal detachments may be seen, rarely 
bilateral. Familiar exudative vitreoretinopathy 
(FEVR) may present with peripheral retinal 
capillary without perfusion; it may be bilateral 
and asymmetric, with strabismus or leukocoria in 
childhood. Phthisis is possible (9). Tough being 
similar to ROP in our patient, there should be 
positive family history and there should be no 
history of prematurity or oxygen therapy.  Stage 5 retinopathy of prematurity in one eye – case report                                                            Gordana Stanković-Babić et al. 
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The paper highlights the importance of 
timely screening for ROP in the prevention of 
blindness due to ROP stage 5, which fortunately 
developed only one eye in our small patient, in 
combination with microphthalmus. 
Effective strategy for decreasing ROP-
related blindness is performing retinal exami-
nations in neonatal intensive care units. All 
interested parties must cooperate in developing 
and implementing full proof screening protocols. 
Hospital officials, nursery personnel, neo-
natologists and ophthalmologists all have areas 
of responsibility in ensuring adequate screening. 
Future safe and nondestructive therapeutic 
strategies combined with preventive approaches 
need to be tailored to the unique developmental 
requirements of the premature infant (23).  
 
Conclusion 
 
Retinopathy of prematurity is the major 
ocular disorder of the neonate and the dominant 
cause of severe visual impairment in childhood. 
Prevalence of ROP and blindness will be 
significantly higher in infants with late retinal 
examinations. Prevention includes adequate 
prenatal care which minimizes premature birth 
and appropriate systemic intensive care which 
lessens the tissue hyperoxia /hypoxia swings. 
Early diagnosis of damage is important in the 
treatment of ROP. 
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PETI STADIJUM RETINOPATIJE PREMATURITETA NA JEDNOM OKU - 
PRIKAZ BOLESNIKA 
 
Gordana Stanković-Babić, Ana Oros, Milena Vujanović i Sonja Cekić 
 
 
Prematurna retinopatija (ROP) je vodeći uzrok slepila kod dece i jedan od 
najznačajnijih razloga slepila u perinatalnom periodu.  
U radu se prikazuje dečak uzrasta devet meseci sa ezotropijom, mikroftalmusom 
i totalnom ablacijom mrežnjače na jednom oku kao poslednjim stadijumom bolesti, a 
koji nije prošao rutinski pregled na ROP. Dečak je rođen u 32. gestacijskoj nedelji, 
telesna masa na rođenju bila je 1670 g. Indirekna oftalmoskopija i ultrasonografija 
levog oka pokazale su peti stadijum prematurne retinopatije. Na desnom oku nalaz je 
bio normalan.  
Prematurna retinopatija danas zahteva prepoznavanje, razumevanje i saradnju 
između oftalmologa, pedijatara, neonatologa. Rana dijagnoza oštećenja je značajna u 
tretmanu ROP-a.  Acta Medica Medianae 2012;51(1):37-41. 
 
Ključne reči: retinopatija prematuriteta, ablacija mrežnjače, slepilo, mikroftalmus  
  
 